Kenya leads in implementing WHO TB/HIV collaborative activities


Moscow, Russia November 17, 2017  Despite the Disease Burden, Kenya has been recognized as a leader in implementing the WHO recommended TB/HIV collaborative activities.

Speaking at Stepped-UP TB/ HIV response Ministerial Panel session, in Moscow today the Principal Secretary for Health, Mr. Julius Korir revealed that in 2016, 95% of TB Patients had a documented HIV test result, with 92% of those found to be HIV-infected put on ART and almost all on Clotrimazole Preventive Therapy. 

“All people living with HIV receiving care and treatment are routinely screened for TB during their clinical visits,” said PS.

Kenya is one of the 30 Countries that account for 89% of all new HIV infections worldwide, with an estimated 1.5 million Kenyans living with HIV, 1.4 million adults and 98,000 children. In 2016, 1.1 million Kenyans living with HIV were receiving care.

Kenya also features on three lists of 30 High Burden Countries for TB, HIV-associated TB, and Multi-Drug Resistant TB.

The PS revealed that Kenya commenced a national scale-up of Isoniazid Preventive Therapy (IPT) in 2015. “To date, close to 600,000 People Living with HIV (50%) have been initiated on IPT, provided as standard care to all those who are newly enrolled in care.”

In addition, the country is implementing TB infection prevention and control in health care and congregate settings to minimize airborne transmission of TB, particularly across health-care facilities visited by People Living with HIV.

“The country has already adopted the latest WHO Global recommendations on TB/HIV and is scaling up policies that ensure Integrated, Patient-Centred delivery of effective prevention, early detection, and prompt treatment, as set out within the 12-point WHO Policy Package on collaborative TB/HIV activities,” he said.

To reduce diagnostic delays and facilitate early access to life-saving treatment, Xpert MTB/RIF is now the first diagnostic test for all people with presumptive TB. Recently Kenya approved the urine based TB-LAM to diagnose TB among people living with HIV.

Mr Korir said the service provision for HIV, TB, and PMTCT has been integrated and implemented using Family-Based Approach to help remove access barriers and reduce delays in TB diagnosis.

HIV/TB testing services have also been expanded to peripheral Health Facilities and Community settings, to ensure coverage of all presumptive and diagnosed TB patients.

“In addition, TB and HIV services are provided at no cost to the patient,” he stressed.

The PS is leading the Kenyan delegation at the WHO Global Ministerial Conference “Ending TB in the Sustainable Development Era: A Multisectoral Response” in Moscow, Russian Federation.